Credits Available: 4.5 AMA PRA Category 1 Credit™ & 4.5 MOC points, 4.5 ACPE

Description: Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western countries, with an age-adjusted incidence of 4.6 per 100,000 individuals per year. As small lymphocytic lymphoma (SLL) refers to the same malignant process with primary nodal involvement rather than blood, these are generally managed as a single condition (CLL/SLL). The selection of therapies for patients with relapsed/refractory CLL/SLL requires consideration of several factors including previous therapies, disease characteristics, and patient-specific factors such as co-morbidities and concurrent medications. Given the recency of new research into these targeted treatments and new approvals, clinicians lack background knowledge of the most current evidence and guideline recommendations in the treatment of CLL/SLL. Even within national guidelines, specific recommendations for initial treatment choice and sequencing are not directed. This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients with relapsed/refractory chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL).

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Assistant
Target Specialties: Hematology, Hematology/Oncology, Oncology

Lisa Nodzon

Moffitt Cancer Center
Lead Advanced Practice Professional

Lisa Nodzon is a Lead Advanced Registered Nurse Practitioner in the Department of Malignant Hematology at H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. She has been practicing there since 2010. Her primary scope of practice encompasses the care and management of malignant hematology patients with an emphasis on chronic leukemias. She has co-authored several peer review journal articles in addition to speaking at the national and state level on topics involving these diseases.

She is dual board certified as an Advanced Oncology Certified and Acute Care Nurse Practitioner. She received her Master of Science in Nursing degree from the University of South Florida in Tampa and PhD degree from the University of Florida in Gainesville, Florida, with a focus on Molecular and Cellular biology. Dr. Nodzon was a Postdoctoral Research Fellow in the Department of Cancer Biology at Mayo Clinic focusing on the development of cell models for colon carcinogenesis.

Dr. Nodzon is an active member of various professional societies including the Advanced Practitioner Society for Hematology and Oncology (APSHO), American Society of Hematology, American Society of Clinical Oncology and Florida Association of Clinical Oncology (FLASCO) and International Cardio-Oncology Society (IC-OS).